Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Approach Continuum to Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations

NCT03195205 is registered in ClinicalTrials.gov with TruCare Internal Medicine & Infectious Disease as lead sponsor.

NCT NCT03195205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03195205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Approach Continuum to Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations
Lead sponsor
TruCare Internal Medicine & Infectious Disease
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2017
Completion date
April 20, 2020
Enrollment
3,051 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c